Behavioural Intervention
TEAM-based Care for Cancer
Recruiting1 award11 criteria
Durham, North Carolina
This trial will test a new way of managing care for cancer patients with comorbidities. 800 patients will be randomly assigned to either usual care or care that includes their primary care physician as an active member of their cancer care team. The goal is to improve chronic disease management and communication among cancer survivors.
Electronic Alerts for High Cholesterol
Recruiting1 award3 criteria
Boston, Massachusetts
This trial is focused on the feasibility of implementing an electronic alert system to notify patients and doctors of high LDL-C values. 400 patients will be randomly selected to either receive notifications or not.
Popular Filters
Trials for Hypercholesterolemia Patients
Genetic Testing
Pharmacogenomic Testing for High Cholesterol
Recruiting1 award3 criteria
Indianapolis, Indiana
This trial aims to address the issue of high-risk cardiovascular disease patients not accepting or sticking to statin medication, even though it is cost-effective in reducing cholesterol levels and CVD risk. The main barriers
Anti-metabolites
Statins + Lifestyle Counseling for High Cholesterol
Recruiting1 awardPhase 2
Winston-Salem, North Carolina
This trial aims to assess a program called EMERALD that provides cardiovascular care to patients in the emergency department who are at risk of heart disease. The goal is to see if this program can help lower
Behavioral Intervention
Church-based Health Intervention for Cardiovascular Disease
Recruiting1 award4 criteria
New Orleans, Louisiana
This trial studies the impact of two approaches to reduce CVD disparities in Black communities in Louisiana. One is a CHW-led multifaceted intervention, the other is a group-based education strategy.
Trials for High Cholesterol Patients
Genetic Testing
Pharmacogenomic Testing for High Cholesterol
Recruiting1 award3 criteria
Indianapolis, Indiana
This trial aims to address the issue of high-risk cardiovascular disease patients not accepting or sticking to statin medication, even though it is cost-effective in reducing cholesterol levels and CVD risk. The main barriers
Anti-metabolites
Statins + Lifestyle Counseling for High Cholesterol
Recruiting1 awardPhase 2
Winston-Salem, North Carolina
This trial aims to assess a program called EMERALD that provides cardiovascular care to patients in the emergency department who are at risk of heart disease. The goal is to see if this program can help lower
Behavioral Intervention
Church-based Health Intervention for Cardiovascular Disease
Recruiting1 award4 criteria
New Orleans, Louisiana
This trial studies the impact of two approaches to reduce CVD disparities in Black communities in Louisiana. One is a CHW-led multifaceted intervention, the other is a group-based education strategy.
Phase 3 Trials
PCSK9 Inhibitor
Oral PCSK9 Inhibitor for High Cholesterol
Recruiting1 awardPhase 3
Port Orange, Florida
This trial is testing a new medication called MK-0616 to see if it can lower bad cholesterol levels in adults with a genetic condition that causes very high cholesterol. These patients often need special treatments because regular medications may not work well for them. The study will measure how much MK-0616 can reduce bad cholesterol over several months.
Monoclonal Antibodies
MK-0616 for High Cholesterol
Recruiting1 awardPhase 3
Daphne, Alabama
This trial is testing a new medication called MK-0616 to see if it can lower bad cholesterol levels in adults with high cholesterol. The study will compare the effects of MK-0616 over several months. The goal is to find out if MK-0616 is safe, effective, and well-tolerated.
RNA-based Therapeutic
Inclisiran for Cardiovascular Disease Prevention
Recruiting1 awardPhase 3
Miramar, Florida
This trial tests whether inclisiran injections can prevent serious heart problems in high-risk adults who haven't had a major heart event yet by lowering their cholesterol levels. Inclisiran is a long-acting treatment that significantly lowers cholesterol.
Behavioral Intervention
Motivational Interviewing for High Cholesterol
Recruiting2 awardsPhase 3
Duluth, Minnesota
This trial aims to help patients with suspected Familial Hypercholesterolemia (FH) by using motivational interviews. These interviews educate patients about their health risks and encourage them to inform their family members. The goal is to improve disease management and early detection in relatives.
Trials With No Placebo
Genetic Testing
Pharmacogenomic Testing for High Cholesterol
Recruiting1 award3 criteria
Indianapolis, Indiana
This trial aims to address the issue of high-risk cardiovascular disease patients not accepting or sticking to statin medication, even though it is cost-effective in reducing cholesterol levels and CVD risk. The main barriers
Anti-metabolites
Statins + Lifestyle Counseling for High Cholesterol
Recruiting1 awardPhase 2
Winston-Salem, North Carolina
This trial aims to assess a program called EMERALD that provides cardiovascular care to patients in the emergency department who are at risk of heart disease. The goal is to see if this program can help lower
Behavioral Intervention
Church-based Health Intervention for Cardiovascular Disease
Recruiting1 award4 criteria
New Orleans, Louisiana
This trial studies the impact of two approaches to reduce CVD disparities in Black communities in Louisiana. One is a CHW-led multifaceted intervention, the other is a group-based education strategy.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.